HomePLYX • NASDAQ
add
Polaryx Therapeutics, Inc
Previous close
$7.56
Day range
$7.20 - $8.28
Year range
$2.20 - $48.91
Market cap
359.81M USD
Avg Volume
1.76M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 911.00K | 26.00% |
Net income | -1.50M | -106.78% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.14M | 11.30% |
Total assets | 5.17M | 3.38% |
Total liabilities | 605.00K | 109.34% |
Total equity | 4.56M | — |
Shares outstanding | 47.34M | — |
Price to book | 75.60 | — |
Return on assets | -40.84% | — |
Return on capital | -46.17% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.50M | -106.78% |
Cash from operations | -1.49M | -73.26% |
Cash from investing | — | — |
Cash from financing | 888.00K | -67.71% |
Net change in cash | -602.00K | -131.85% |
Free cash flow | -378.38K | — |
About
Founded
2014
Headquarters
Website
Employees
7
